Global Direct-to-consumer Genetic Health Sequencing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Direct-to-consumer Genetic Health Sequencing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Direct-to-consumer genetic testing is differentthese genetic tests are marketed directly to customers via television, print advertisements, or the Internet, and the tests can be bought online or in stores. Customers send the company a DNA sample and receive their results directly from a secure website or in a written report. Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process.
Direct-to-consumer Genetic Health Sequencing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Direct-to-consumer Genetic Health Sequencing market is projected to reach US$ 1930.9 million in 2033, increasing from US$ 1025 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Demand from Online and Offline are the major drivers for the industry.
The increasing incidence of genetic disorders and hereditary diseases has led to a greater demand for genetic testing and gene sequencing services for diagnosis and risk assessment.
Gene sequencing is widely used in cancer research to identify specific genetic mutations and biomarkers associated with different cancer types, aiding in the development of targeted therapies.
The popularity of DTC genetic testing services, which provide individuals with personalized genetic information, has contributed to the growth of the gene sequencing service market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Direct-to-consumer Genetic Health Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
Segment by Type
Diagnostic Screening
PGD Relationship Testing
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Direct-to-consumer Genetic Health Sequencing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Direct-to-consumer Genetic Health Sequencing introduction, etc. Direct-to-consumer Genetic Health Sequencing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Direct-to-consumer Genetic Health Sequencing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Direct-to-consumer Genetic Health Sequencing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Direct-to-consumer Genetic Health Sequencing market is projected to reach US$ 1930.9 million in 2033, increasing from US$ 1025 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Demand from Online and Offline are the major drivers for the industry.
The increasing incidence of genetic disorders and hereditary diseases has led to a greater demand for genetic testing and gene sequencing services for diagnosis and risk assessment.
Gene sequencing is widely used in cancer research to identify specific genetic mutations and biomarkers associated with different cancer types, aiding in the development of targeted therapies.
The popularity of DTC genetic testing services, which provide individuals with personalized genetic information, has contributed to the growth of the gene sequencing service market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Direct-to-consumer Genetic Health Sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes
Segment by Type
Diagnostic Screening
PGD Relationship Testing
Segment by Application
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Direct-to-consumer Genetic Health Sequencing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Direct-to-consumer Genetic Health Sequencing introduction, etc. Direct-to-consumer Genetic Health Sequencing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Direct-to-consumer Genetic Health Sequencing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.